BIOX Stock Overview
Bioceres Crop Solutions Corp., junto con sus filiales, ofrece soluciones para la productividad de los cultivos.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 4/6 |
| Past Performance | 3/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Bioceres Crop Solutions Corp. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$12.65 |
| 52 Week High | US$14.20 |
| 52 Week Low | US$9.76 |
| Beta | 0.58 |
| 1 Month Change | -4.46% |
| 3 Month Change | -6.23% |
| 1 Year Change | 12.20% |
| 3 Year Change | -5.17% |
| 5 Year Change | 159.75% |
| Change since IPO | 158.16% |
Recent News & Updates
Bioceres Needs To Add Clarity Around Borrowings
Mar 23Bioceres Crop Solutions (NASDAQ:BIOX) Takes On Some Risk With Its Use Of Debt
Feb 03
Recent updates
Bioceres Needs To Add Clarity Around Borrowings
Mar 23Bioceres Crop Solutions (NASDAQ:BIOX) Takes On Some Risk With Its Use Of Debt
Feb 03Does Bioceres Crop Solutions (NASDAQ:BIOX) Have A Healthy Balance Sheet?
Oct 04Bioceres Crop Solutions Corp.'s (NASDAQ:BIOX) Popularity With Investors Is Clear
Jun 21Here's Why Bioceres Crop Solutions (NASDAQ:BIOX) Is Weighed Down By Its Debt Load
May 09Bioceres: A Resilient Small Cap With Conference Appearances After Thursday's Earnings
Sep 06Bioceres Crop Solutions jumps 15% after investor pitch
Aug 23We Think Bioceres Crop Solutions (NASDAQ:BIOX) Is Taking Some Risk With Its Debt
Apr 10Bioceres Has Not Resolved Its Major Risks And Is Growing Based On Commodities Bullishness
Mar 31Is Now The Time To Look At Buying Bioceres Crop Solutions Corp. (NASDAQ:BIOX)?
Mar 17Is Bioceres Crop Solutions Corp. (NASDAQ:BIOX) Trading At A 21% Discount?
Nov 13Bioceres Crop Solutions (NASDAQ:BIOX) Shareholders Will Want The ROCE Trajectory To Continue
Jul 08Estimating The Intrinsic Value Of Bioceres Crop Solutions Corp. (NASDAQ:BIOX)
Jun 16What Does Bioceres Crop Solutions Corp.'s (NASDAQ:BIOX) Share Price Indicate?
May 26Bioceres partners with Havanna to offer consumers HB4 wheat-based sustainable products
May 10Does Bioceres Crop Solutions (NASDAQ:BIOX) Have A Healthy Balance Sheet?
May 05Bioceres Crop Solutions (NYSEMKT:BIOX) Shareholders Will Want The ROCE Trajectory To Continue
Apr 05Are Investors Undervaluing Bioceres Crop Solutions Corp. (NYSEMKT:BIOX) By 22%?
Mar 10Bioceres Crop Solutions (NYSEMKT:BIOX) Shareholders Booked A 53% Gain In The Last Year
Feb 12Shareholder Returns
| BIOX | US Chemicals | US Market | |
|---|---|---|---|
| 7D | 0.2% | -0.8% | -0.8% |
| 1Y | 12.2% | 12.4% | 25.9% |
Rentabilidad frente al sector: BIOX obtuvo unos resultados inferiores a los del sector US Chemicals , que el año pasado arrojó un rendimiento del 12.4%.
Rentabilidad vs. Mercado: BIOX obtuvo unos resultados inferiores a los del mercado US, que fue del 17.9% el año pasado.
Price Volatility
| BIOX volatility | |
|---|---|
| BIOX Average Weekly Movement | 4.0% |
| Chemicals Industry Average Movement | 5.4% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.7% |
| 10% least volatile stocks in US Market | 3.0% |
Precio estable de las acciones: BIOX no ha tenido una volatilidad de precios significativa en los últimos 3 meses.
Volatilidad a lo largo del tiempo: La volatilidad semanal de BIOX (5%) se ha mantenido estable durante el año pasado.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2001 | n/a | Federico Trucco | https://biocerescrops.com |
Bioceres Crop Solutions Corp., junto con sus filiales, ofrece soluciones para la productividad de los cultivos. Opera a través de los segmentos de Semillas y Productos Integrados, Protección de Cultivos y Nutrición de Cultivos. El segmento de Semillas y Productos Integrados provee rasgos de semillas, germoplasmas y paquetes de tratamiento de semillas para cultivos más saludables y de mayor rendimiento.
Bioceres Crop Solutions Corp. Fundamentals Summary
| BIOX fundamental statistics | |
|---|---|
| Market cap | US$794.77m |
| Earnings (TTM) | US$21.96m |
| Revenue (TTM) | US$454.53m |
36.2x
P/E Ratio1.7x
P/S RatioIs BIOX overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| BIOX income statement (TTM) | |
|---|---|
| Revenue | US$454.53m |
| Cost of Revenue | US$266.91m |
| Gross Profit | US$187.62m |
| Other Expenses | US$165.67m |
| Earnings | US$21.96m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.35 |
| Gross Margin | 41.28% |
| Net Profit Margin | 4.83% |
| Debt/Equity Ratio | 66.5% |
How did BIOX perform over the long term?
See historical performance and comparison